Higher In-Hospital Mortality Among Asian Americans Undergoing Transjugular Intrahepatic Portosystemic Shunt Procedure

Overview

Journal Visc Med

Date 2024 Aug 19

PMID 39157728

Authors

Renxi Li

Shawn Sarin

Affiliations

Soon will be listed here.

Abstract

Background: Transjugular intrahepatic portosystemic shunt (TIPS) is a procedure to alleviate portal hypertension in patients with decompensated liver cirrhosis. While prior research highlighted racial disparities in TIPS, Asian Americans were not included in the investigation. This study aimed to investigate disparities in the immediate postprocedural outcomes among Asian American patients who underwent TIPS.

Methods: The study identified Asian American and Caucasian patients who underwent TIPS in the National Inpatient Sample from Q4 2015-2020. Preprocedural factors, including demographics, comorbidities, primary payer status, and hospital characteristics, were matched by 1:2 propensity-score matching between the groups. In-hospital outcomes after TIPS were examined.

Results: There were 6,658 patients who underwent TIPS with 128 (1.92%) Asian Americans and 4,574 (68.70%) Caucasians, where 218 Caucasians were matched to all Asian Americans. Asian Americans had higher in-hospital mortality (14.06% vs. 7.34%, = 0.04) and higher total hospital charge (253,756 ± 37,867 vs. 163,391 ± 10,265 US dollars, = 0.02). The occurrence of hepatic encephalopathy, acute kidney injury, transfers out to other hospital facilities, and length of stay did not differ between cohorts.

Conclusion: Despite their heightened risk for cirrhosis, Asian Americans are significantly underrepresented in TIPS and had higher in-hospital mortality after TIPS. This highlights the need for enhanced access to diagnosis and treatment care of liver cirrhosis for Asian Americans.

References

Nolte W, Wiltfang J, Schindler C, Munke H, Unterberg K, Zumhasch U . Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology. 1998; 28(5):1215-25. DOI: 10.1002/hep.510280508. View

Lee S, Martinez G, Ma G, Hsu C, Robinson E, Bawa J . Barriers to health care access in 13 Asian American communities. Am J Health Behav. 2009; 34(1):21-30. PMC: 6628721. DOI: 10.5993/ajhb.34.1.3. View

Lee E, Kuei A, Saab S, Busuttil R, Durazo F, Han S . Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2016; 22(25):5780-9. PMC: 4932213. DOI: 10.3748/wjg.v22.i25.5780. View

Ninoi T, Nakamura K, Kaminou T, Nishida N, Sakai Y, Kitayama T . TIPS versus transcatheter sclerotherapy for gastric varices. AJR Am J Roentgenol. 2004; 183(2):369-76. DOI: 10.2214/ajr.183.2.1830369. View

Choi Y, Yoon C, Park J, Chung J, Kwon J, Choi G . Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol. 2003; 4(2):109-16. PMC: 2698068. DOI: 10.3348/kjr.2003.4.2.109. View

Vizzutti F, Schepis F, Arena U, Fanelli F, Gitto S, Aspite S . Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes. Intern Emerg Med. 2020; 15(1):37-48. DOI: 10.1007/s11739-019-02252-8. View

Trivedi P, Rochon P, Durham J, Ryu R . National Trends and Outcomes of Transjugular Intrahepatic Portosystemic Shunt Creation Using the Nationwide Inpatient Sample. J Vasc Interv Radiol. 2016; 27(6):838-45. DOI: 10.1016/j.jvir.2015.12.013. View

Helzberg J, Parish A, Niedzwiecki D, Kim C, Patel Y, Wilder J . Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes. BMJ Open Gastroenterol. 2022; 9(1). PMC: 8796249. DOI: 10.1136/bmjgast-2021-000747. View

Elixhauser A, Steiner C, Harris D, Coffey R . Comorbidity measures for use with administrative data. Med Care. 1998; 36(1):8-27. DOI: 10.1097/00005650-199801000-00004. View

10.

Setiawan V, Stram D, Porcel J, Lu S, Le Marchand L, Noureddin M . Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort. Hepatology. 2016; 64(6):1969-1977. PMC: 5115980. DOI: 10.1002/hep.28677. View

11.

Chen Jr M, Dang J . Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control. World J Gastroenterol. 2015; 21(42):11924-30. PMC: 4641114. DOI: 10.3748/wjg.v21.i42.11924. View

12.

Lo G . The use of transjugular intrahepatic portosystemic stent shunt (TIPS) in the management of portal hypertensive bleeding. J Chin Med Assoc. 2014; 77(8):395-402. DOI: 10.1016/j.jcma.2014.05.010. View

13.

Moore B, White S, Washington R, Coenen N, Elixhauser A . Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data: The AHRQ Elixhauser Comorbidity Index. Med Care. 2017; 55(7):698-705. DOI: 10.1097/MLR.0000000000000735. View